South Africa declassifies cannabis, reclassifies CBD and THC
South Africa has decided to remove the cannabis plant from the list of controlled substances, but has classified CBD and THC in a way that allows their use under certain conditions.
The country has also exempted industrial hemp from medical regulation, but has set the THC level in the plant at 0.2% and in finished products at 0.001%, effectively limiting its potential uses.
CBD as a dietary supplement and a medication
CBD is considered both a dietary supplement and a medication. It is listed in Schedule 4 of the Controlled Substances List and requires a prescription, except when it is packaged in containers containing 600 mg or less of CBD and limited to a maximum dose of 20 mg per day, in which case it is then regulated in addition to Appendix 0.
The Annex includes many over-the-counter medications, such as aspirin, and dietary supplements, such as vitamins. This classification means, however, that only products manufactured in accordance with GMP standards will be authorized, and only when the producers are registered as drug manufacturers and the products themselves are registered with the South African Health Regulatory Authority (SAHPRA).
THC and Industrial Hemp
The classification of THC under Schedule 4 paves the way for a medical cannabis industry in South Africa.
The cannabis plant was removed from Schedule 7—which is reserved for strictly controlled substances—and quickly came under the jurisdiction of the Ministry of Agriculture.
It thus exempts industrial hemp from classification, but sets the limit for this exemption at 0.2%—a very low threshold that is more in line with European conditions than with those in South Africa. Malawi For example, it has set its limit at 1% of THC to promote local varieties and foster a hemp industry.
Processed products, on the other hand, will have a THC limit set at just 0.001%, whether they are fibers or food products.
-
Business4 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand3 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Cannabis in France3 weeks ago
Medical cannabis: The Greens introduce two amendments to accelerate its widespread adoption
-
Cannabis in Spain4 weeks ago
Spain: Medical Cannabis Is Coming to About 50 Hospitals
-
Business4 weeks ago
British patients now have access to THCV-rich cannabis flowers
-
Cannabis in Canada3 weeks ago
A Canadian study reveals the pleasant psychotropic effects of high-dose CBD


You must be logged in to post a comment Login